Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Thomas V. Colby, MD"'
Autor:
Anjali Saqi, MD, MBA, Kevin O. Leslie, MD, Andre L. Moreira, MD, PhD, Sylvie Lantuejoul, MD, PhD, Catherine Ann Shu, MD, Naiyer A. Rizvi, MD, Joshua R. Sonett, MD, Kosei Tajima, MS, Shawn W. Sun, PharmD, Barbara J. Gitlitz, MD, Thomas V. Colby, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 5, Pp 100310- (2022)
The efficacy of neoadjuvant treatment for NSCLC can be pathologically assessed in resected tissue. Major pathologic response (MPR) and pathologic complete response (pCR), defined as less than or equal to 10% and 0% viable tumor cells, respectively, a
Externí odkaz:
https://doaj.org/article/e87ed4b0d3b2461eb53709e10f63f4a4
